CochLear Book Value Per Share 2023-2024 | CHEOY
Current and historical book value per share for CochLear (CHEOY) from 2023 to 2024. Book value per share can be defined as the amount of equity available to shareholders expressed on a per common share basis. CochLear book value per share for the three months ending June 30, 2024 was $.
| CochLear Book Value Per Share Historical Data | |||
|---|---|---|---|
| Date | |||
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.924B | $1.488B |
| Cochlear Limited provides implantable hearing solutions principally in the Americas, Europe, the Middle East, Africa and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories and Baha bone conduction implants. Cochlear Limited is based in Sydney, Australia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $84.844B | 10.53 |
| Cencora (COR) | United States | $43.438B | 16.33 |
| DiDi Global (DIDIY) | China | $22.990B | 0.00 |
| Natera (NTRA) | United States | $21.203B | 0.00 |
| ICON (ICLR) | Ireland | $17.541B | 15.62 |
| Viatris (VTRS) | United States | $14.824B | 4.57 |
| Avantor (AVTR) | United States | $14.429B | 21.63 |
| Revvity (RVTY) | United States | $13.631B | 23.68 |
| BioMerieux (BMXMF) | France | $12.250B | 0.00 |
| Solventum (SOLV) | United States | $11.390B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.405B | 29.31 |
| Doximity (DOCS) | United States | $9.999B | 58.86 |
| Charles River Laboratories (CRL) | United States | $9.340B | 18.05 |
| HealthEquity (HQY) | United States | $8.390B | 42.09 |
| Sonic Healthcare (SKHHY) | Australia | $8.095B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.339B | 29.51 |
| Amplifon S.p.A (AMFPF) | Italy | $5.864B | 29.89 |
| Sotera Health (SHC) | United States | $3.858B | 20.64 |
| Organon (OGN) | United States | $3.853B | 3.89 |
| BrightSpring Health Services (BTSG) | United States | $3.018B | 64.18 |
| Surgery Partners (SGRY) | United States | $2.706B | 30.85 |
| Concentras Parent (CON) | United States | $2.456B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.405B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.216B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.188B | 0.00 |
| Premier (PINC) | United States | $2.054B | 10.69 |
| PACS (PACS) | United States | $1.971B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.738B | 45.60 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.720B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.639B | 0.00 |
| Progyny (PGNY) | United States | $1.510B | 30.57 |
| Establishment Labs Holdings (ESTA) | $1.268B | 0.00 | |
| Embecta (EMBC) | United States | $1.177B | 8.23 |
| CareDx (CDNA) | United States | $1.154B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.119B | 10.95 |
| AMN Healthcare Services Inc (AMN) | United States | $0.935B | 6.33 |
| Agilon Health (AGL) | United States | $0.791B | 0.00 |
| SBC Medicals (SBC) | United States | $0.572B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.566B | 14.81 |
| InnovAge Holding (INNV) | United States | $0.534B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.516B | 0.00 |
| DocGo (DCGO) | United States | $0.438B | 16.50 |
| Sonida Senior Living (SNDA) | United States | $0.436B | 0.00 |
| Enhabit (EHAB) | United States | $0.390B | 33.70 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.284B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.281B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.237B | 0.00 |
| LifeMD (LFMD) | United States | $0.227B | 0.00 |
| Biodesix (BDSX) | United States | $0.215B | 0.00 |
| MultiPlan (MPLN) | United States | $0.209B | 0.00 |
| Beauty Health (SKIN) | United States | $0.200B | 0.00 |
| Nutex Health (NUTX) | United States | $0.189B | 0.00 |
| ModivCare (MODV) | United States | $0.177B | 9.60 |
| So-Young (SY) | China | $0.097B | 16.41 |
| Ascend Wellness Holdings (AAWH) | United States | $0.093B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| Singular Genomics Systems (OMIC) | United States | $0.049B | 0.00 |
| OncoCyte (OCX) | United States | $0.039B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.025B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Oncology Institute (TOI) | United States | $0.022B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| KindlyMD (KDLY) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |